abnormal susceptibility to injury induced morbidity/mortality_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>

http://metadb.riken.jp/0020344B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg

abnormal susceptibility to injury induced morbidity/mortality_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transmembrane protein 219
  http://metadb.riken.jp/db/mgi_rdf/MGI:1915992

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tmem219<tm1(KOMP)Vlcg>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6J.B6N-Tmem219<tm1(KOMP)Vlcg>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• http://purl.obolibrary.org/obo/MP_0020344

文献

http://purl.org/net/cito/citesAsAuthority

• Chang-Min. Lee, et.al., IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses., Nature communications, 2016, 7
  http://rdf.ncbi.nlm.nih.gov/pubmed/27629921